Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
Silodosin
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/25/2020
WiNeWsE
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021
N-[(1R)-2-[4-(1-Methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxamide
Approved for COVID-19 treatment (China, India, Russia) Experimental Antiviral Sep/18/2020
N-({(2S)-1-[(3R)-3-Amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-YL}methyl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Berzosertib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
Nebivolol
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021
Zinc sulfate
Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/16/2021
Triazavirin
Potential treatment - clinical evidence Experimental Antiviral Sep/08/2020
Methotrexate 
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/14/2020
Ferroquine
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/08/2020
ZINC104875569
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
Toremifene
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/28/2020
Celgosivir
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2020
Adenosine diphosphate ribose
Potential treatment - theoretical effect Natural product Antiviral Sep/08/2020
4-(3,4-Dihydroxyphenyl)-7-methoxy-5-[(2S,3R,4S,5S)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one
Potential treatment - theoretical effect Natural product Antiviral Sep/08/2020
Leuprorelin
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020
Lypressin
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020
Withanone
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021
MXB-4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
Boceprevir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021